Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Study on the Safety and Effects of BIIB122 for Patients with LRRK2 ...
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with ...
Efectos de BIIB122 en la Enfermedad de Parkinson Asociada a LRRK2
Structure of the RIPK2 12317 -XIAP BIR2 1542240 complex. (A) Ribbon ...
BIIB122 – The Science of Parkinson's
BIIB122 for Early-Stage Parkinson's Disease Clinical Trial 2024 | Power
First Patient Treated in Phase 2a Trial of Investigational BIIB122 for ...
New publication: LRRK2 Inhibition by BIIB122 in Healthy Participants ...
Phase 2b Study of Parkinson Disease LRRK Inhibitor BIIB122 Initiated ...
Dosing Begins for LIGHTHOUSE, Parkinson’s Clinical Trial of BIIB122 ...
Biogen and Denali Terminate Phase 3 LIGHTHOUSE Study of BIIB122 in ...
BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD ...
RPK2-LRR adopts a superhelical structure comparable to BRI1-LRR. (A ...
Badanie nad bezpieczeństwem i działaniem BIIB122 u pacjentów z chorobą ...
RCSB PDB - 8U7L: Cryo-EM structure of LRRK2 bound to type II inhibitor ...
Smartphone-based digital assessments in the LUMA trial of BIIB122 ...
Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s ...
Inhibition of Parkinson’s disease–related LRRK2 by type I and type II ...
Chemical structures of BI-D and BIB-2. | Download Scientific Diagram
Full article: Leucine-rich repeat kinase 2 (LRRK2): an update on the ...
LRRK2 in Parkinson's disease: upstream regulation and therapeutic ...
中国不同年龄人群的PD发病率（1990-2019) - 2024年08月 - 行业研究数据 - 小牛行研
Denali Therapeutics Continues To Have Plenty Of Moving Parts (NASDAQ ...
The luminance of a lighthouse – The Science of Parkinson's
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for ...
(a) The coordination surrounding view of Bi2 and Bi1 in complex 1. (b ...
Exploring the damage of mtDNA – The Science of Parkinson's
Frontiers | Development of mutation-selective LRRK2 kinase inhibitors ...
figure10.jpg
LRRK2/NUAK1/TYK2-IN-1 | | TargetMol
Structural studies identify angiotensin II receptor blocker-like ...
BIIB-122 Market Size, Forecast, and Emerging Insight - 2032
DNL151 / Denali Therap, Biogen
dnli-20201231
An Update on the Interplay between LRRK2, Rab GTPases and Parkinson’s ...
2 Parkinson's Trials to Test Oral BIIB122/DNL151 in Slowing Progression
Oral Parkinson's Therapy Safely Lowers LRRK2 Activity in Phase 1 Trials
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study ...
BIIB129 | BTK inhibitor | CAS 2770960-52-4 | Selleck
Oral Therapy BIIB122/DNL151 Dosed in Parkinson's Clinical Trial LUMA
Discovery and Preclinical Characterization of BIIB129, a Covalent ...
Denali Therapeutics: Intriguing Yet Expensive Technology Awaits 'Buy ...
渤健终止LRRK2抑制剂BIIB122 III期临床研究，治疗帕金森病患者
Frontiers | The Emerging Functions of LRRK2 and Rab GTPases in the ...
LRRK2 and idiopathic Parkinson’s disease: Trends in Neurosciences
A step forward for LRRK2 inhibitors in Parkinson’s disease | Science ...
BIIB129 | BTK Inhibitor | MedChemExpress
Characterization of ROCK inhibitors as LRRK2 inhibitors (A) The ...
多國聯合開展臨床！帕金森新藥BIIB122片進入II期臨床階段！ - 每日頭條
Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways ...
Efficacy and pharmacodynamic properties of the LRRK2 kinase inhibitor ...
Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich ...
Parkinsonism & Related Disorders
BIIB122的1期临床试验 - 2024年08月 - 行业研究数据 - 小牛行研
Characterization of a selective inhibitor of the Parkinson’s disease ...
Two 1D Chain Structures Derived from Alkaline-Earth Metal Complexes and ...
Structural binding site comparisons reveal Crizotinib as a novel LRRK2 ...
Chemical structures of representative selective LRRK2 inhibitors ...
In Vitro Metabolism of BIIB021, an Inhibitor of Heat Shock Protein 90 ...
難病治験ウェブ | jRCT2031220519 | パーキンソン病患者を対象としたBIIB122の有効性及び安全性を評価する多施設共同無作為 ...
Deal: Biogen to co-develop and co-commercialize LRRK2 inhibitors with ...
Design of an LRRK2 inhibitor-desensitized mutant (A) Structural model ...
BIIB122的1期临床试验 - 行业研究数据 - 小牛行研
CD122/IL2RB General Information | Sino Biological
Type II kinase inhibitors that target Parkinson’s disease–associated ...
Recent Advances in the Treatment of Genetic Forms of Parkinson’s ...
LRRK2 Structure-Based Activation Mechanism and Pathogenesis
LRRK2 Kinase Inhibitors as Possible Therapy for Parkinson’s Disease and ...
Selective Stabilization of LRRK2 Kinase Conformations Reveals Distinct ...
Ocrelizumab Reduces Thalamic Volume Loss, Cenobamate Shines in C017 ...
Kinase inhibitory effects of LRRK2-IN1, TTT-3002 and H-1152 on ...
Structures of MLSBK Antibiotics Bound to Mutated Large Ribosomal ...
The 2D chemical structures of ATP competitive LRRK2 inhibitors ...
La maladie de Parkinson : de la génétique aux thérapies ciblées
Rationale for LRRK2 inhibition in sporadic Parkinson’s disease and the ...
Energy Rich Compounds - Phosphoenolpyruvate, 1,3 Bisphosphoglycerate ...
